Winkler Martin Sebastian, Rissiek Anne, Priefler Marion, Schwedhelm Edzard, Robbe Linda, Bauer Antonia, Zahrte Corinne, Zoellner Christian, Kluge Stefan, Nierhaus Axel
Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
PLoS One. 2017 Aug 3;12(8):e0182427. doi: 10.1371/journal.pone.0182427. eCollection 2017.
Sepsis is defined as a dysregulated immune response to infection. Impaired immune response in sepsis, often described as endotoxin tolerance, is characterized by unresponsiveness of monocytes on lipopolysaccharide (LPS) stimulation to release tumor necrosis factor α (TNFα). Furthermore, decreased monocyte surface protein expression of human leucocyte antigen DR (HLA-DR) is a marker for changes of the innate immune response during sepsis. Quantitative polymerase chain reaction (qPCR) and flow-cytometry (FACS) have been used to measure protein or gene expression of HLA-DR. We aimed to determine whether changes in mRNA expression of HLA-DR are associated with impaired TNFα response in human sepsis.
Surface protein together with mRNA expression of HLA-DR were measured by FACS and qPCR in a cohort of 9 sepsis patients and compared to 10 pre-operative control patients in a prospective study. In addition, 20 patients with post-surgical inflammation, 20 patients with sepsis or septic shock were included and TNFα was determined following ex vivo stimulation of whole blood with 500 pg/mL LPS. Total RNA was prepared from whole blood and subjected to qPCR analysis for expression analysis of HLA-DR alpha (HLA-DRA) to correlate TNFα response with HLA-DRA expression.
Patients with sepsis presented higher numbers of monocytes in peripheral blood (P<0.001) but decreased surface protein and mRNA HLA-DR levels when compared to controls. In all patients mRNA expression of HLA-DRA was decreased by approximately 70% compared to controls (P<0.01) and was lowest in patients with sepsis or septic shock (P<0.01). TNFα response to LPS was decreased in all patients (median 319 pg/mL versus controls 1256 pg/mL; P<0.01) and lowest in patients with sepsis or septic shock (median 128 pg/mL; P<0.01). HLA-DRA correlated positively with TNFα response in all study participants (r +0.60, P<0.001) and within patients (r +0.67, P<0.001). The TNFα:HLA-DRA ratio correlated negatively with severity and the Sequential Organ Failure Assessment (SOFA) score (Spearman's rho -0.59, P<0.001).
In this study, HLA-DRA expression was associated with a functional assay of the innate immune response. Future interventional studies aimed at the immune response during sepsis could make use of these methods for optimizing target groups based on biological plausibility and intervention effectiveness.
脓毒症被定义为对感染的免疫反应失调。脓毒症中受损的免疫反应,通常被描述为内毒素耐受,其特征是单核细胞在脂多糖(LPS)刺激下释放肿瘤坏死因子α(TNFα)的反应迟钝。此外,人类白细胞抗原DR(HLA-DR)单核细胞表面蛋白表达降低是脓毒症期间先天性免疫反应变化的一个标志。定量聚合酶链反应(qPCR)和流式细胞术(FACS)已被用于测量HLA-DR的蛋白或基因表达。我们旨在确定HLA-DR的mRNA表达变化是否与人类脓毒症中TNFα反应受损相关。
在一项前瞻性研究中,通过FACS和qPCR测量了9例脓毒症患者队列中HLA-DR的表面蛋白及mRNA表达,并与10例术前对照患者进行比较。此外,纳入了20例术后炎症患者、20例脓毒症或脓毒性休克患者,在用500 pg/mL LPS对全血进行体外刺激后测定TNFα。从全血中提取总RNA,并进行qPCR分析以检测HLA-DRα(HLA-DRA)的表达,从而将TNFα反应与HLA-DRA表达相关联。
与对照组相比,脓毒症患者外周血中的单核细胞数量更多(P<0.001),但表面蛋白和HLA-DR mRNA水平降低。与对照组相比,所有患者中HLA-DRA的mRNA表达均降低了约70%(P<0.01),在脓毒症或脓毒性休克患者中最低(P<0.01)。所有患者对LPS的TNFα反应均降低(中位数319 pg/mL,对照组为1256 pg/mL;P<0.01),在脓毒症或脓毒性休克患者中最低(中位数128 pg/mL;P<0.01)。在所有研究参与者中,HLA-DRA与TNFα反应呈正相关(r +0.60,P<0.001),在患者体内也是如此(r +0.67,P<0.001)。TNFα:HLA-DRA比值与严重程度及序贯器官衰竭评估(SOFA)评分呈负相关(Spearman等级相关系数-0.59,P<0.001)。
在本研究中,HLA-DRA表达与先天性免疫反应的功能检测相关。未来针对脓毒症期间免疫反应的干预性研究可利用这些方法,基于生物学合理性和干预效果来优化目标群体。